Amjevita Trademark Details
Word Mark | Amjevita |
---|---|
Status | Alive 681 — Publication/Issue Review Complete |
Serial Number | 86904419 |
---|---|
Status Date | Tuesday, September 20, 2016 |
Filing Date | Tuesday, September 20, 2016 |
Attorney | Richard Y. Kim |
Correspondent
RICHARD Y. KIM
MCDERMOTT WILL & EMERY LLP
500 NORTH CAPITOL STREET, N.W.
WASHINGTON, DC 20001
MCDERMOTT WILL & EMERY LLP
500 NORTH CAPITOL STREET, N.W.
WASHINGTON, DC 20001
Case File Statements
Goods & Services | Pharmaceutical preparations, namely, pharmaceutical preparations, substances and biosimilars used for the treatment of bone, joint, intestine, colon, skin, lung, eye, bladder, blood cells, and blood vessel diseases and disorders; pharmaceutical preparations, substances and biosimilars for the treatment of autoimmune and immune system, inflammatory, inflammatory bowel, gastrointestinal, musculoskeletal, dermatological, pulmonary, respiratory, oncological, and ophthalmic diseases and disorders; pharmaceutical preparations, substances and biosimilars used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, hidradenitis suppurativa, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, uveitis, choroidal neovascularization, Pyoderma Gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancers, asthma, and refractory asthma |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, February 17, 2016 |
Primary Code | 005 |
Trademark Timeline
-
Feb 11 2016Trademark application filed with USPTO
-
Feb 15 2016New Application Entered In Tram
-
Feb 17 2016New Application Office Supplied Data Entered In Tram
-
May 27 2016Assigned To Examiner
-
May 30 2016Notification of Priority Action E-Mailed
-
May 30 2016Priority Action E-Mailed
-
May 30 2016Priority Action Written
-
Sep 01 2016Teas Response To Office Action Received
-
Sep 10 2016Assigned To Lie
-
Sep 16 2016Approved For Pub - Principal Register
-
Sep 16 2016Teas/email Correspondence Entered
-
Sep 16 2016Correspondence Received In Law Office
-
Sep 20 2016Law Office Publication Review Completed